-transparent.png){kind=logo}
A case history is reported or renal failure during and after treatment with carboplatin for 3 days, total dose 750 mg/m2, in a conditioning regimen prior to autologous bone marrow transplantation. Pretreatment renal function was compromised after nephrectomy and chemotherapy with cisplatin. A decrease in glomerular filtration rate concurred with a decrease in excretion of platinum in the urine and an increase in urinary beta 2 microglobulin. Treatment with high-dose carboplatin in patients with impaired renal function and previous treatment with cisplatin may lead to further loss of renal function.
Related Publications
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
December 1995,
Medical and pediatric oncology,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
March 1989,
Annals of internal medicine,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
November 1993,
Oncology,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
May 2005,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
January 1996,
Bone marrow transplantation,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
March 2009,
Cancer chemotherapy and pharmacology,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
March 2002,
Bone marrow transplantation,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
August 1994,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
February 1992,
Lancet (London, England),
P O Mulder, and
D T Sleijfer, and
E G de Vries, and
D R Uges, and
N H Mulder
September 1985,
Cancer treatment reviews,
